Moreover, in the brains of AD patients, sustained production of Aβ can induce upregulation of BACE1-AS, thereby creating a positive feedback mechanism that further promotes Aβ expression and worsening the pathological deterioration (Li et al., 2019). This evidence concerns the gene BACE1 and Alzheimer disease.